JiangSu WuZhong Pharmaceutical Development Co., Ltd.

SHSE:600200 Stock Report

Market Cap: CN¥6.7b

JiangSu WuZhong Pharmaceutical Development Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Qunshan Qian

Chief executive officer

CN¥1.3m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Is Making Moderate Use Of Debt

Jun 06
JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Is Making Moderate Use Of Debt

Many Still Looking Away From JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)

Mar 12
Many Still Looking Away From JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)

CEO

Qunshan Qian (51 yo)

no data

Tenure

CN¥1,284,000

Compensation

Mr. Qunshan Qian is Chairman & CEO of JiangSu WuZhong Pharmaceutical Development Co., Ltd.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.